HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BEAUTICONTROL SCULPTIQUE BODY CONTOURING CREME

This article was originally published in The Rose Sheet

Executive Summary

BEAUTICONTROL SCULPTIQUE BODY CONTOURING CREME works by "attacking the fat deposits on women's thighs, hips, waists, abdomen and legs,...combats fluid retention and increases the natural process of fat elimination, giving a more toned look wherever it is applied," the firm said. Sculptique will be available Oct. 1 through the over 37,000 BeautiControl representatives in the U.S. and Canada. The product does not contain aminophylline, a prescription asthma treatment found in other thigh reduction creams. However, Sculptique does contain theophyllisane C. Both aminophylline and theophyllisane C are derivatives of theophylline. FDA currently is investigating the use of aminophylline and theophylline in cosmetic products due to consumer concerns and the popularity of the ingredient ("The Rose Sheet" Feb. 14, In Brief).
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS000880

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel